Gilead Worth $125 After Earnings: Morgan Stanley
July 29, 2015 at 07:59 AM EDT
In a report published Wednesday, Morgan Stanley analyst Matthew Harrison maintained an Overweight rating on Gilead Sciences, Inc. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.